Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's kind of why I asked. Any idea how one can find the version of this applicable to the current 510(K)?
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222701.pdf
"The USA FDA approval is for the laser surgery instrument."
Is it? That's all I wanted to know.
Do you know what the specific predicate device was?
What's the meaning of the info at the link?
Obviously we aren't getting it. The entire market is wrong about the value of IPIX....only une petite handful of people have it figured out. The market'll get it right eventually....just wait and see.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.004
-0.001 (-20.00%)
Volume: 611,401
Total Trades: 30
Daily Volume: $2,884
Only a matter of time.
His last voluntary public statement appears to have been made in August. I guess he's busy.
Seems he's been busy for a while. From the current OTCMarkets:
BUSINESS DESCRIPTION
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
ps. I didn't make this up:
"candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future"
Maybe a gag order isn't such a bad idea.
Last I heard the 36 healthy patients had been recruited and that's all I heard.
2nd request:
Please consider adding this as a Sticky: https://ctri.nic.in/Clinicaltrials/showallp.php?mid1=67454&EncHid=&userName=Karveer Meditech
"I think it safe to say that a great majority of ADVFN Plc revenue is derived from advertising and franchise fees."
Maybe so. The fact remains that I make a financial contribution and you freeload...it surprises me not that you can't see how those things are connected.
"I also think it safe to say the primary reason you subscribe is for access to the search feature"
Absolutely (although there are other helpful features). Not only for the purpose of catching people trying to revise history but also to have ready access to the Company's past as it has been chronicled here. BTW, it's very difficult to search your posts and find anything relevant to the operations of the Company. A free membership doesn't preclude such things, you know.
"Oh well, I don't mind."
You don't mind what?
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0052
0.0003 (6.12%)
Volume: 394,545
Total Trades: 40
Daily Volume: $1,940
"He has paid to post anything he likes on this board"
Bullshit. While you and he are free to post on this board (not exactly everything you like, btw....there are a few rules), neither of you has paid for the privilege. Others (ahem) are funding your posting privileges.
I don't mind, but it would be nice to see some meaningful content once in a while to the extent that you are capable.
I'll get you started:
I like IPIX because.....
25 convincing words or less will do. Maybe talk about the drug development progress or the financial status or even something about what you feel "about the future of IPIX".....I don't mind a little RELEVANT science fiction.
From where I sit:
There are no active clinical trials. The few development partners have bailed.
There's very little cash in the till, no accessible registration statement in place so the paucity of available shares can't be sold, and no prospects for a lender. There has not even been the kind of hint that there's a clamoring to buy IPIX assets as we used to see buried in a filing.
The future's not ours to see, que sera, sera (just ask Snowy).
Go!
Thanks. But why do you never write about IPIX?
Is it really "because I don't believe I know any more about the future of IPIX than anyone frequenting the IPIX board"?
"I'm going to pretend for a moment that you asked me about why I maintain the stance that I do."
Who would ask you that? If you actually have a stance it is very well disguised.
"Based on the above facts I can't imagine my having any sinister value worth compensating much less putting me on some sort of regular payroll."
What facts? Me neither.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0049
-0.0007 (-12.50%)
Volume: 253,099
Total Trades: 17
Daily Volume: $ 1,351
Avg trade execution....$79.47
The thing's a gold mine.
"Posted by airplane guy:
The good news is that Polymedix tested Bril against 11 types of weaponized anthrax strains and it stopped every strain it was tested against. "
Just a few notes:
Neither Polymedix nor brilacidin were mentioned in the article linked in the post, which was from 2010 and which you chose not to link, nor does it mention that brilacidin was tested against 11 types of weaponized anthrax strains and that it stopped every strain it was tested against.
The word "anthrax" doesn't turn up in a search of the IPIX website or any of the press releases linked therein.
Do you know what the phrase "low hanging fruit" means?
"why exactly are you here"
There it is again....the question that wouldn't die. It should though, because the fact that this thing (IPIX) hasn't been able to get out of his own way hasn't had anything to do with who is here and who isn't. The Company's price performance matches its operating performance perfectly.
Yep. More than twice as many as he could have added just a year ago. Patience pays off sometimes.
"They have done all they say they will do and they meet their schedules and they do not spend much money."
The financials that they provide to IPIX suggest that they kinda don't spend much money (specifically they spent about 25% of the ipix investment between 6/22 and 9/23) but CEO CPA acknowledges that those numbers aren't subject to the same review as IPIX's own numbers.
I noticed yesterday that this appears in the SERIES A PREFERRED SHARE PURCHASE AGREEMENT between IPIX and Beamed, then Squalus:
"The Company (Squalus) has delivered to each Purchaser its audited financial statements for the fiscal years ended December 31, 2020 and December 31, 2021 and its unaudited internal management accounts as of and for the quarter ended March 31, 2022 (collectively, the “Financial Statements”)."
So Squalus HAD auditors at some point. Where'd they go? If they were still around there wouldn't have been any need for this:
"As a result of the assessment of the Company’s internal control over financial reporting as of June 30, 2023, management concluded that the Company’s accounting procedures relevant to an unconsolidated foreign investment are not sufficiently formal that management can determine whether the applicable control objectives are met and adequate documentation supporting the procedures is in place. Specifically, the Company does not have sufficient controls to conclude that data from the unconsolidated foreign investee underlying the Company’s financial statements is captured completely, accurately and timely, in accordance with the Company’s policies and procedures."
Who shitcanned the Squalus auditors and why?
And Dougwur is still free to answer. But whether he does or he doesn't won't change the fact that the TOTAL Dollar Volume of today's trades was $1,239.
Hanukkah?
Hardly anybody did. (Dollar Volume....$1,239.)
I don't know what an LDE is but I knew the date when I typed it.
Cellceutix: December to Be Momentous Month in Company's History
November 24, 2014
https://www.globenewswire.com/en/news-release/2014/11/24/955423/0/en/Cellceutix-December-to-Be-Momentous-Month-in-Company-s-History.html
But where'd it go? The Great Ehraser made it disappear. Poof!
http://www.ipharminc.com/press-release
Guess he meant some other December. Maybe this one?
These are some pretty dark thoughts. Have you shared them with the Company? (http://www.ipharminc.com/contact-us)
"The only thing I can say is that he has a major collective lawsuit if he goes BK and $4 million just went to BeaMed rather than operations for an agreement on Brilacidin. That’s a transfer of assets by any terms knowing may cause the early BK of the company. Then he would have to answer to why he didn’t state Brilacidin as not effective and the investment to BeaMed is doubly catastrophic to share holders."
That's the first time I've seen you say that brilacidin is ineffective.
OK, so no bubbles no troubles then. But expected since when?
On September 23 there was still hope expressed here: "And the Alfasigma Brilacidin license is worth USD$24 million after milestones. Plus royalty."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172909484&txt2find=alfasigma
Is this what you mean by expected?
" The Company recently learned that Alfasigma is considering terminating further work under the License Agreement, although as of the date of this report, Alfasigma has not notified the Company of the termination of the License Agreement or a cessation of further work under the License Agreement."
That's from the CEO himself 2 weeks ago.
Are you braggin' or complainin'?
IPIX is now free to pursue this:
https://static1.squarespace.com/static/5715352e20c647639137f992/t/5beac1250ebbe846eb4b031e/1542111528589/IPI+IBD+Innovate+2018+Poster+%28final%29.pdf
All the CEO CPA has to do is scrape together some funds and duplicate those results, no? Maybe he can terminate the unfiled BeaMed Agreement by returning some preferred shares and get some cash back.
Of course if it was that easy I guess AlfaSigma wouldn't have bailed.
Hold on. Would you like to suggest that AS was afraid that IPIX would hurt their procspects by breaking out its vaunted oral B fo IBD?
Notice of Annual Meeting of Stockholders
To Be Held on Saturday, January 13, 2024
To Our Stockholders:
NOTICE IS HEREBY GIVEN, that the Annual Meeting of Stockholders (the “Annual Meeting”), of NanoViricides, Inc. (the “Company” or “NanoViricides”) will be held on Saturday, January 13, 2024, at 10:00 a.m., Eastern Daylight Time, at Hampton Inn & Suites Stamford, 26 Mill River Street, Stamford, CT 06902, for the following purposes:
1. To re-elect Anil Diwan as a Class I director for a two-year term expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until their earlier resignation or removal (Proposal 1);
2. To conduct an advisory vote on the compensation of the Company’s named Executive Officers (Proposal 2);
3. To approve an award of 10,204 shares of Series A Convertible Preferred Stock to Anil Diwan in connection with the extension of his employment as the Company’s President (Proposal 3);
4. To ratify the appointment of EisnerAmper, LLP, the Company’s independent registered accounting firm for the fiscal year ending June 30, 2024 (Proposal 4); and
5. To transact such other business as may properly come before the Annual Meeting, including to consider any procedural matters incident to the conduct of the Annual Meeting, such as the postponement of the Annual Meeting in order to solicit additional proxies to vote in favor of the matters presented at the Annual Meeting.
"The Company’s Board of Directors (the “Board of Directors”) has fixed the close of business on November 13, 2023, as the record date for the determination of holders of record of the Company’s common stock entitled to notice of, and to vote at, the Annual Meeting. A list of shareholders of record of the Company as of the record date will remain open for inspection during the Annual Meeting until the closing of the polls thereat."
"If Alfasigma were to terminate the License Agreement or cease further work under the License Agreement, the Company could be required to impair some or all of the patent assets associated with Brilacidin."
The good news for shareholders is that most of their patent assets have already been charged off.
Yep. Spanky and the Gang skimmed 82 bucks worth of bottles and cans out of the local recycling boxes. Gonna get some new plywood for the clubhouse with their profits.
"But the value potential truth has not changed."
Is that a technical or a fundamental measurement? How is it calculated?
From your link.
"4. The role of due diligence: Conducting thorough research and due diligence is essential for investors to make informed decisions and protect themselves from falling victim to stock bashers' manipulations. By analyzing reliable sources of information such as financial statements, industry trends, and expert opinions, investors can gain a more accurate understanding of a company's fundamentals and potential risks."
Protect yourself:
https://www.sec.gov/cgi-bin/browse-edgar?company=innovation+pharmaceuticals&match=starts-with&filenum=&State=&Country=&SIC=&myowner=exclude&action=getcompany
Sadly you were deprived of a reliable source of information when this was scrubbed of valuable information not once but twice (at least), leaving one to wonder about the reliability of what remains:
http://www.ipharminc.com/
Unfortunately the facts can't protect you when they're lousy, but they're still the facts.
"6. The importance of constructive discussions: Online forums should strive to foster constructive discussions that promote the exchange of diverse perspectives and insights. Encouraging users to provide well-reasoned arguments supported by facts and encouraging healthy skepticism can help counteract the influence of stock bashers"
https://storage.courtlistener.com/recap/gov.uscourts.dcd.225086/gov.uscourts.dcd.225086.158.2.pdf
What do you get for $149., pluto?
"Each and every charge in the amount of $149.99 charged to the following credit
cards between September 1, 2018 and December 31, 2020, was for the personal use
and benefit of defendant Keith Berman and did not constitute business-related
expenses incurred by or on behalf of Decision Diagnostics Corp… The parties
further agree and stipulate that this stipulation be entered into evidence at defendant
Keith Berman’s trial in the above-captioned matter."
Stunning.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.007 0.002 (40.00%)
Volume: 860,185
Day Range: 0.005 - 0.0082
Last Trade Time: 3:29:26 PM EST
Dollar Volume: $ 5,590
Big day! News on Monday?
I don't believe that IPIX's problems are due to the actions of some bogeymen and I KNOW that you can't show that they are.
"Simple logic when applied without negative bias toward IPIX should have every investor here feeling optimistic about the alliance between IPIX and BeaMed."
Maybe.
Maybe not:
"Nerby is to Prurisol what Deep Throat was to Watergate. Stay strong my friends. The long awaited rewards from our investment in IPIX will soon begin to flow, and more importantly, relief to those who suffer from this dreadful disease will be one step closer to reality."
February 12, 2018 $.67
Today $0.0067
It's called financial analysis but you can refer to it as Debbie Downer shtick if you like. Such shtick comes about as a result of Downer financials....I know it's difficult for you to avoid but there's nothing to be gained by shooting a messenger of facts.
"This discussion about finances came out in the 10Q. You were doing your Debbie Downer shtick before then."
That's because it actually came out in the 10K, not the 10Q. Of course one would have to have read the 10K to know that.
And I won't be deterred from repeating it because it's important:
"The principal executive officer and principal financial officer of the Company (that's just one guy in this company) has concluded that the Company’s disclosure controls and procedures are not effective due to the material weakness in the Company’s internal control over financial reporting as of June 30, 2023 as described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023."
"If we fail to properly remediate this or any future material weakness or deficiencies, our ability to produce accurate and timely financial statements may be impaired."
"This material weakness could result in a misstatement of the recorded equity investment as well as the equity in loss from equity investment that would not be prevented or detected on a timely basis."
No serious investor would downplay the importance of a CEO's conclusion, especially considering that the CEO is a CPA, that his Company’s disclosure controls and procedures are not effective. And no serious investor would buy the shares of such a Company, certainly no institutional investor would.
One would have to be a real knucklehead to think that mm's or anyone else was involved in manipulating the price of shares that traded less than $3,000 during the entire day. You don't really think that, do you?
"I don't recall any consideration by the IPIX opposition team around the possibility that this may have been an elegant strategic move on Leo's part."
I can't speak for the WHOLE team but in my view sending half of the Company's cash overseas in return for a non-controlling interest in a startup business whose finances they admittedly can't be sure of was something other than an elegant strategic move. It was an inexplicable crapshoot.
What are you talking about?
"BeaMed loading before the merger is announced? "
Loading? $2,449 worth....staggering.
And the price is still below yesterday's close.
I hope people are paying attention.
From April:
"Squalus is seeking leading candidates for positions of VP R&D, System Engineer, and Project Manager, with relevant industry and technical experience."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171753458
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171753589
Per Linkedin today:
4 employees.
Director of System Engineering
System Integration Engineer @BeaMed
Founder & CEO at neoLaser, Co-Founder at BeaMed
Biomedical Engineer
"LinkedIn members who’ve listed BT BeaMedical Technologies / BeaMed as their current workplace on their profile."
Need an account for more info.
"It's all slime balls have is ancient history n today's price per share."
And all you have is the fantasy that they have no connection to each other. And that the sun'll come out tomorrow. Tomorrow, Tomorrow.....
Good luck, Annie.